Uluman Şişman

Uluman Şişman

Auto-generated profile, based on publicly available information

Uluman Şişman

Koç Üniversitesi, Ortopedi ve Travmatoloji Anabilim Dalı, İstanbul

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2026 in TOTBİD Araştırma Dergisi
Verified
Journal Article
Closed access
MEMehmet Eren
Mehmet Eren
KOKağan Oral
Kağan Oral
BGBuğra Güllü
Buğra Güllü
İTİbrahim Selçuk Tutuş
İbrahim Selçuk Tutuş
UŞUluman Şişman
Uluman Şişman
OBOlgar Birsel
Olgar Birsel



10 March 2022 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
EUEGE ANIL UCAR
EGE ANIL UCAR
MKMehmet Batuhan Karakus
Mehmet Batuhan Karakus
Mustafa GüldanMustafa Güldan
Mustafa Güldan
SSSelin Merve Sahin
Selin Merve Sahin
USUluman Sisman
Uluman Sisman
SGSinem Ezgi Gulmez
Sinem Ezgi Gulmez
Objective: Irrational use of antibacterials is a concern during the COVID-19 pandemic. Hospital pharmacoepidemiology studies are important for evaluating the rational use of medicines, especially antibacterials, during pandemics. Defined daily doses (DDD) and drug utilization 90% (DU90%) are established methods for the evaluation of drug utilization. We aimed to evaluate antibacterial utilization in a tertiary hospital setting at Koç University Hospital (KUH). Materials and Methods: This cross-sectional, descriptive study was retrospectively conducted with data extracted from KUH Inpatient Electronic Order System (CP) and was carried out for a period of one year. Antibacterial utilization of adult (aged ≥ 18 years) inpatients, who were prescribed at least one type of systemic antibacterial (ATC code J01), was evaluated using the recommended parameter DDD/100 admission and compared between 6 months before COVID-19 and during COVID-19 periods. March 11, 2020, the very first COVID-19 diagnosed case in Turkey, was set as the cutoff date of the 6-month period for the selection of the compared antibacterials using the DU90% method. Results: Finally, 3280 of 5942 and 2605 of 4942 prescriptions for pre-COVID-19 and COVID-19 periods were included, respectively. Antibacterial utilization according to DDD/100 admissions increased from 193.96 to 201.26 DDD/100 admissions after the initiation of COVID-19 pandemic. The most utilized antibacterials were piperacillin and enzyme inhibitors in pre-COVID-19 period, whereas meropenem was utilized the most during COVID-19 period. Azithromycin utilization increased by 656.24%, whereas clarithromycin utilization decreased by 52.12%. Antibacterials were utilized most in general surgery department, with an increase of 17.57%. Conclusion: There is an increase in antibacterial utilization in KUH during COVID-19 pandemic, especially reserved antibacterials, which is a concern for antibacterial resistance. Keywords: Pharmacoepidemiology, antibiotics, drug utilization, COVID-19 pandemic.

22 April 2026 in TOTBİD Araştırma Dergisi
Verified
Journal Article
Closed access
CGCaner Günerbüyük
Caner Günerbüyük
İTİbrahim Selçuk Tutuş
İbrahim Selçuk Tutuş
UŞUluman Şişman
Uluman Şişman
KOKağan Oral
Kağan Oral
KHKoray Hacıoğlu
Koray Hacıoğlu
OBOlgar Birsel
Olgar Birsel